| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |